Shopping Cart
- Remove All
Your shopping cart is currently empty
Anti-EIF5A2 Antibody (3T444)
😃Good
Catalog No. TMAY-02775
Alias eukaryotic translation initiation factor 5A2, eIF5AII, EIF-5A2
Anti-EIF5A2 Antibody (3T444) is a Rabbit antibody targeting EIF5A2. Anti-EIF5A2 Antibody (3T444) can be used in ELISA.
Anti-EIF5A2 Antibody (3T444)
Anti-EIF5A2 Antibody (3T444)
😃Good
Catalog No. TMAY-02775Alias eukaryotic translation initiation factor 5A2, eIF5AII, EIF-5A2
Anti-EIF5A2 Antibody (3T444) is a Rabbit antibody targeting EIF5A2. Anti-EIF5A2 Antibody (3T444) can be used in ELISA.
| Pack Size | Price | Availability | Quantity |
|---|---|---|---|
| 100 μL | $270 | 7-10 days |
Bulk & Custom
Add to Cart
Questions
View MoreContact us for more batch information
Resource Download
Product Introduction
Bioactivity
Related Conjugates and Formulations
Antigen Details
Chemical Properties
| Description | Anti-EIF5A2 Antibody (3T444) is a Rabbit antibody targeting EIF5A2. Anti-EIF5A2 Antibody (3T444) can be used in ELISA. |
| Alias | eukaryotic translation initiation factor 5A2, eIF5AII, EIF-5A2 |
| Ig Type | Monoclonal Rabbit IgG |
| Clone | 3T444 |
| Reactivity | Human |
| Application | ELISA |
| Recommended Dose | ELISA: 1:5000-1:10000 |
| Antibody Type | Monoclonal |
| Host Species | Rabbit |
| Construction | This antibody was obtained from a rabbit immunized with purified, recombinant Human EIF5A2 (rh EIF5A2; TMPY-03795; Q9GZV4; Met1-Lys153). |
| Purification | Protein A |
| Appearance | Liquid |
| Formulation | 0.2 μm filtered solution in PBS |
| Research Background | Eukaryotic translation initiation factor 5A2 (EIF5A2) has been demonstrated to be upregulated in numerous types of human cancer and is associated with cancer progression. Silencing of EIF5A2 in the NSCLC cells resulted in the downregulation of the tumorigenic proteins, apoptosis regulator Bcl-2 and myc proto-oncogene protein, and upregulation of E-cadherin, suggesting that EIF5A2 promotes proliferation and metastasis through these proteins. EIF5A2 may therefore serve as a novel therapeutic target for the treatment of NSCLC. EIF5A2 might be a novel therapeutic target for the inhibition of NPC progress. EIF5A2 overexpression may contribute to cancer progression and poor prognosis, it could be a novel potential prognostic marker for FIGO stage I-II cervical cancer. EIF5A2 upregulation plays an important oncogenic role in gastric cancer. EIF5A2 may represent a new predictor for poor survival and is a potential therapeutic target for gastric cancer. The eukaryotic initiation factor 5A2 (EIF5A2) over-expression enhances HCC cell metastasis. EIF5A2, as a target of PI3K/Akt, promotes melanoma cell invasion and may serve as a promising prognostic marker and a potential therapeutic target for melanoma. |
| Conjucates | Unconjugated |
| Immunogen | Recombinant Human EIF5A2 Protein (TMPY-03795) |
| Antigen Species | Human |
Stability & Storage
| Stability & Storage | Store at 2°C-8°C for 1 month. Store at -20°C or -80°C for 12 months. Avoid repeated freeze-thaw cycles. Preservative-Free. |
| Transport | Shipping with blue ice. |
Sci Citations
Calculator
For example, your dosage is 10 mg/kg Each animal weighs 20 g, and the dosage volume is 100 μL . 
Tech Support
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc
Preview
Related Tags: buy Anti-EIF5A2 Antibody (3T444) | purchase Anti-EIF5A2 Antibody (3T444) | Anti-EIF5A2 Antibody (3T444) cost | order Anti-EIF5A2 Antibody (3T444)
- TOP
Feedback
Hello! How can I help you today? 
Copyright © 2015-2025 TargetMol Chemicals Inc. All Rights Reserved.